Which Initial Combination for Type 2Diabetes

The initial combination is the starting pharmacological intervention together with lifestyle changes for the management of most components of the Cardiovascular-Kidney Metabolic Syndrome (American Heart Association; November 2023) e.g. hypertension, heart failure, dyslipidemia, and chronic kidney disease. For type 2 diabetes, the VERIFY trial (Vildagliptin/Metformin vs. Metformin; 2019) showed better outcomes for the initial combination vs. stepwise approach.

Publication Details

Journal: Egyptian Society of Diabetes and Lipidology Journal
Published: 2024-10-01
DOI: https://doi.org/10.21608/esdlj.2024.456245
Primary Topic: Diabetes and associated disorders
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Which Initial Combination for Type 2Diabetes

Oct 1, 2024

Egyptian Society of Diabetes and Lipidology Journal

Diabetes and associated disorders

article

Which Initial Combination for Type 2Diabetes

October 1, 2024article en

Abstract

Egyptian Society of Diabetes and Lipidology JournalVol. 4(2)

Openalex Percentile: Top 71%

Diabetes and associated disorders

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Which Initial Combination for Type 2Diabetes · Egyptian Society of Diabetes and Lipidology Journal (2024) | TGRS Research Map | TGRS